SG11201803023UA - Compositions comprising minerals and their use - Google Patents

Compositions comprising minerals and their use

Info

Publication number
SG11201803023UA
SG11201803023UA SG11201803023UA SG11201803023UA SG11201803023UA SG 11201803023U A SG11201803023U A SG 11201803023UA SG 11201803023U A SG11201803023U A SG 11201803023UA SG 11201803023U A SG11201803023U A SG 11201803023UA SG 11201803023U A SG11201803023U A SG 11201803023UA
Authority
SG
Singapore
Prior art keywords
minerals
compositions
Prior art date
Application number
SG11201803023UA
Inventor
Nora Schneider
Jonas Hauser
Zolezzi Irma Silva
Tinu Mary Samuel
Sean Deoni
Tamas Bartfai
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of SG11201803023UA publication Critical patent/SG11201803023UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
SG11201803023UA 2016-03-30 2016-12-13 Compositions comprising minerals and their use SG11201803023UA (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662315134P 2016-03-30 2016-03-30
US201662315152P 2016-03-30 2016-03-30
US201662315142P 2016-03-30 2016-03-30
US201662315163P 2016-03-30 2016-03-30
US201662315158P 2016-03-30 2016-03-30
US201662328112P 2016-04-27 2016-04-27
PCT/EP2016/080793 WO2017167419A1 (en) 2016-03-30 2016-12-13 Compositions comprising minerals and their use

Publications (1)

Publication Number Publication Date
SG11201803023UA true SG11201803023UA (en) 2018-05-30

Family

ID=57614347

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201803023UA SG11201803023UA (en) 2016-03-30 2016-12-13 Compositions comprising minerals and their use
SG11201806431RA SG11201806431RA (en) 2016-03-30 2017-03-30 Compositions comprising minerals and their use

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201806431RA SG11201806431RA (en) 2016-03-30 2017-03-30 Compositions comprising minerals and their use

Country Status (8)

Country Link
EP (1) EP3436032A1 (en)
CN (2) CN108367025A (en)
BR (2) BR112018011366A2 (en)
CA (2) CA3004044A1 (en)
MX (2) MX2018011678A (en)
PH (3) PH12018501129A1 (en)
SG (2) SG11201803023UA (en)
WO (2) WO2017167419A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201924696A (en) 2017-12-01 2019-07-01 瑞士商耐斯泰克公司 Maternal supplement
US20210338720A1 (en) * 2018-08-27 2021-11-04 Tinu Mary Samuel Compositions and methods for the treatment of mastitis
SG10201900604TA (en) * 2019-01-23 2020-08-28 Agency For Science Technology And Research Astarstar Pre-natal beta-cryptoxanthin benefits children
US20230040010A1 (en) * 2020-01-16 2023-02-09 Societe Des Produits Nestle S.A. Compositions and methods for the treatment of mastitis
WO2024038010A1 (en) 2022-08-18 2024-02-22 Société des Produits Nestlé S.A. Kit to promote developmental myelination

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE84680T1 (en) 1987-12-23 1993-02-15 Nestle Sa PROCESS FOR THE MANUFACTURE OF A WHEY PROTEIN HYDROLYSATE AND A HYPOALLERGENIC FOOD.
EP0880902A1 (en) 1997-05-27 1998-12-02 Nestlé Produkte AG Process for treating a raw whey material
MXPA01010778A (en) 1999-04-29 2003-08-20 Nestle Sa Composition for an infant formula having a low threonine content.
WO2006099233A2 (en) * 2005-03-10 2006-09-21 Sciele Pharma, Inc. Compositions and methods for the treatment of osteoporosis and inflammatory joint disease
CN101902918A (en) * 2007-10-19 2010-12-01 方塔拉合作集团有限公司 Keep or increase the method for growth or cognitive development
CN102946728B (en) * 2010-03-12 2015-09-23 帝斯曼知识产权资产管理有限公司 Maternal sialic acid is supplemented
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
CN102488011B (en) * 2011-12-21 2013-07-31 澳优乳业(中国)有限公司 Formula milk powder containing arachidonic acid for pregnant and parturient women and preparation method thereof

Also Published As

Publication number Publication date
BR112018067730A2 (en) 2019-01-08
CN108778294A (en) 2018-11-09
WO2017167896A1 (en) 2017-10-05
BR112018011366A2 (en) 2018-12-04
SG11201806431RA (en) 2018-10-30
CA3015594A1 (en) 2017-10-05
EP3436032A1 (en) 2019-02-06
WO2017167419A1 (en) 2017-10-05
PH12018501129A1 (en) 2019-01-28
MX2018011678A (en) 2019-01-10
PH12018501831A1 (en) 2019-05-15
CA3004044A1 (en) 2017-10-05
CN108367025A (en) 2018-08-03
MX2022014684A (en) 2023-01-11
PH12018501128A1 (en) 2019-01-28

Similar Documents

Publication Publication Date Title
HK1243741A1 (en) Tnfrsf-binding agents and uses thereof
HUE057087T2 (en) Tigit-binding agents and uses thereof
GB201411197D0 (en) Composition and use thereof
ZA201803451B (en) Probiotic compositions and uses thereof
PT3018183T (en) Haloolefin-based composition and use thereof
IL250568B (en) Anti-methanogenic compositions and uses thereof
IL264813B (en) 2-oxo-imidazopyridines and their use
HK1257642A1 (en) Cucurbituril compositions and their use
IL262045B (en) Uv-protective compositions and their use
GB201502002D0 (en) Uses and compositions
GB201608762D0 (en) Compositions and uses thereof
SG11201803023UA (en) Compositions comprising minerals and their use
SG11201803027PA (en) Compositions comprising phospholipid and their use
HK1250915A1 (en) Composition and uses thereof
PL3197273T3 (en) Pesticide compositions and use thereof
GB201502026D0 (en) Uses and compositions
GB201501991D0 (en) Uses and compositions
IL251238A0 (en) Mineral based compositions and use thereof
GB201705626D0 (en) Compositions and methods
ZA201902130B (en) Microparticle composition and use thereof
ZA201807665B (en) Methods and compositions
GB201411196D0 (en) Composition and use thereof
GB201715820D0 (en) Compositions and methods
SG11201803025VA (en) Compositions comprising vitamins and their use
GB201614897D0 (en) Compositions and uses thereof